These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6142675)

  • 1. Effect of azathioprine and carbon tetrachloride on induction of hyperplastic liver nodule and hepatocellular carcinoma by diethylnitrosamine and N-2-fluorenylacetamide in rats.
    Sakata T; Watanabe A; Takei N; Shiota T; Nakatsukasa H; Fujiwara M; Kobayashi M; Nagashima H
    Ann N Y Acad Sci; 1983; 417():288-93. PubMed ID: 6142675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of carbon tetrachloride and azathioprine on diethylnitrosamine and N-2-fluorenylacetamide-induced hyperplastic liver nodule and hepatocellular carcinoma.
    Sakata T
    Acta Med Okayama; 1984 Dec; 38(6):511-24. PubMed ID: 6524446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dietary selenium concentration on the development of enzyme-altered liver foci and hepatocellular carcinoma induced by diethylnitrosamine or N-acetylaminofluorene in rats.
    LeBoeuf RA; Laishes BA; Hoekstra WG
    Cancer Res; 1985 Nov; 45(11 Pt 1):5489-95. PubMed ID: 2865004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of various chemicals on the development of hyperplastic liver nodules in hepatectomized rats treated with N-nitrosodiethylamine or N-2-fluorenylacetamide.
    Ito N; Tatematsu M; Nakanishi K; Hasegawa R; Takano T; Imaida K; Ogiso T
    Gan; 1980 Dec; 71(6):832-42. PubMed ID: 7274629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinction between liver neoplasm promoting and syncarcinogenic effects demonstrated by exposure to phenobarbital or diethylnitrosamine either before or after N-2-fluorenylacetamide.
    Williams GM; Furuya K
    Carcinogenesis; 1984 Feb; 5(2):171-4. PubMed ID: 6697434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of vitamin E on the induction and evolution of enzyme-altered foci in the liver of rats treated with diethylnitrosamine.
    Ura H; Denda A; Yokose Y; Tsutsumi M; Konishi Y
    Carcinogenesis; 1987 Nov; 8(11):1595-600. PubMed ID: 2889537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the promoting effects of various agents in induction of preneoplastic lesions in rat liver.
    Ito N; Tsuda H; Hasegawa R; Imaida K
    Environ Health Perspect; 1983 Apr; 50():131-8. PubMed ID: 6191977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of low-dose N-2-fluorenylacetamide-induced hyperplastic liver nodules by pre-existing cirrhosis.
    Watanabe A; Yamauchi Y; Kobayashi M; Nagashima H
    Carcinogenesis; 1987 Oct; 8(10):1445-8. PubMed ID: 2888544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of different initiation protocols in the resistant hepatocyte model.
    Espandiari P; Robertson LW; Srinivasan C; Glauert HP
    Toxicology; 2005 Jan; 206(3):373-81. PubMed ID: 15588927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic cell loss and proliferation induced by N-2-fluorenylacetamide, diethylnitrosamine, and aflatoxin B1 in relation to hepatoma induction.
    Nishizumi M; Albert RE; Burns FJ; Bilger L
    Br J Cancer; 1977 Aug; 36(2):192-7. PubMed ID: 199226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of O4-ethyldeoxythymidine accumulation, hepatic initiation and hepatocellular carcinoma induction in rats continuously administered diethylnitrosamine.
    Dyroff MC; Richardson FC; Popp JA; Bedell MA; Swenberg JA
    Carcinogenesis; 1986 Feb; 7(2):241-6. PubMed ID: 2868805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diethyl-nitrosamine hepatocarcinogenesis in cirrhotic rats.
    Zalatnai A; Lapis K
    Acta Morphol Hung; 1987; 35(3-4):211-8. PubMed ID: 3137785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of ellagic acid on N-2-fluorenylacetamide-induced liver carcinogenesis in male ACI/N rats.
    Tanaka T; Iwata H; Niwa K; Mori Y; Mori H
    Jpn J Cancer Res; 1988 Dec; 79(12):1297-303. PubMed ID: 2906931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modifying potential of thirty-one chemicals on the short-term development of gamma-glutamyl transpeptidase-positive foci in diethylnitrosamine-initiated rat liver.
    Tsuda H; Hasegawa R; Imaida K; Masui T; Moore MA; Ito N
    Gan; 1984 Oct; 75(10):876-83. PubMed ID: 6150874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of carbon tetrachloride, ethanol and acetaldehyde on diethylnitrosamine-induced hepatocarcinogenesis in rats.
    Cho KJ; Jang JJ
    Cancer Lett; 1993 Jun; 70(1-2):33-9. PubMed ID: 8330298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of hepatocarcinogenesis by sequential administration of chemicals: summation versus promotion effects.
    Williams GM; Katayama S; Ohmori T
    Carcinogenesis; 1981; 2(11):1111-7. PubMed ID: 6119166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The DEN and CCl4 -Induced Mouse Model of Fibrosis and Inflammation-Associated Hepatocellular Carcinoma.
    Uehara T; Pogribny IP; Rusyn I
    Curr Protoc Pharmacol; 2014 Sep; 66():14.30.1-14.30.10. PubMed ID: 25181010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissimilar patterns of promotion by di(2-ethylhexyl)phthalate and phenobarbital of hepatocellular neoplasia initiated by diethylnitrosamine in B6C3F1 mice.
    Ward JM; Rice JM; Creasia D; Lynch P; Riggs C
    Carcinogenesis; 1983 Aug; 4(8):1021-9. PubMed ID: 6872148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dietary fat on the initiation of hepatocarcinogenesis by diethylnitrosamine or 2-acetylaminofluorene in rats.
    Glauert HP; Lay LT; Kennan WS; Pitot HC
    Carcinogenesis; 1991 Jun; 12(6):991-5. PubMed ID: 1675161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of hyperplastic liver nodules in hepatectomized rats treated with 3'-methyl-4-dimethylaminoazobenzene, benzo[a]pyrene or phenobarbital before or after exposure to N-2-fluorenylacetamide.
    Hasegawa R; Tatematsu M; Tsuda H; Shirai T; Hagiwara A; Ito N
    Gan; 1982 Apr; 73(2):264-9. PubMed ID: 6288500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.